149 related articles for article (PubMed ID: 32811232)
1. The effects of progesterone treatment on nuchal translucency in women with threatened miscarriage.
Karadağ C; Yoldemir T; Demircan S; Çalışkan E
J Obstet Gynaecol; 2021 May; 41(4):601-604. PubMed ID: 32811232
[TBL] [Abstract][Full Text] [Related]
2. The effects of exogenous oral micronized progesterone on first trimester aneuploidy screening markers in women with threatened miscarriage: a matched case control study.
Karaca I; Erdoğan ŞV; Doğan K; Alay I; Ince O; Yıldırım Karaca S; Comba C; Bahceci E; Erdoğan A; Ozturk E; Ekin M
J Matern Fetal Neonatal Med; 2022 Apr; 35(7):1224-1229. PubMed ID: 32456488
[TBL] [Abstract][Full Text] [Related]
3. Does progesterone therapy increase nuchal translucency in women with threatened miscarriage?
Keçecioğlu M; Tokmak A; Keçecioğlu TS; Akselim B; Karakaya BK; Taşçı Y
Ginekol Pol; 2016; 87(5):390-4. PubMed ID: 27304657
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research].
Borowski D; Czuba B; Cnota W; Hincz P; Czekierdowski A; Gajewska J; Jaczyńska R; Ceran A; Włoch A; Wyrwas D; Wiełgoś M; Szymusik I; Szaflik K; Sodowski K
Ginekol Pol; 2007 May; 78(5):384-7. PubMed ID: 17867331
[TBL] [Abstract][Full Text] [Related]
5. The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy.
Ziolkowska K; Dydowicz P; Sobkowski M; Tobola-Wrobel K; Wysocka E; Pietryga M
Ginekol Pol; 2019; 90(3):161-166. PubMed ID: 30950006
[TBL] [Abstract][Full Text] [Related]
6. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
7. Normal range of intracranial translucency in healthy Turkish pregnancies and its association with first trimester maternal serum biochemistry and ductus venosus pulsatility index. .
Artunc-Ulkumen B; Pala HG; Uyar Y; Bulbul-Baytur Y; Koyuncu FM
Ginekol Pol; 2014 Oct; 85(10):738-41. PubMed ID: 25546923
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
9. The effects of dydrogesterone treatment on first-trimester aneuploidy screening markers and nuchal translucency in women with threatened miscarriage.
Yıldız E; Timur B
Turk J Obstet Gynecol; 2023 Mar; 20(1):16-21. PubMed ID: 36908009
[TBL] [Abstract][Full Text] [Related]
10. Effects of exogenous progesterone on fetal nuchal translucency: an observational prospective study.
Giorlandino C; Cignini P; Padula F; Giannarelli D; d'Emidio L; Aloisi A; Plotti F; Angioli R
Am J Obstet Gynecol; 2015 Mar; 212(3):335.e1-7. PubMed ID: 25305408
[TBL] [Abstract][Full Text] [Related]
11. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
[TBL] [Abstract][Full Text] [Related]
12. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
13. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
14. The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy.
Spencer K; Cicero S; Atzei A; Otigbah C; Nicolaides KH
Prenat Diagn; 2005 Oct; 25(10):927-9. PubMed ID: 16088864
[TBL] [Abstract][Full Text] [Related]
15. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
16. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
Prats P; Rodríguez I; Comas C; Puerto B
Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
[TBL] [Abstract][Full Text] [Related]
17. Reference centile charts of first-trimester aneuploidy screening & Doppler parameters for Indian population.
Kumar M; Singh S; Sharma K; Singh R; Ravi V; Gupta U; Bhattacharjee J
Indian J Med Res; 2018 Oct; 148(4):427-434. PubMed ID: 30666005
[TBL] [Abstract][Full Text] [Related]
18. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
[TBL] [Abstract][Full Text] [Related]
19. The significance of maternal blood pregnancy-associated plasma protein A (PAPP-A) and free beta-subunit of human chorionic gonadotropin (β-hCG) levels for the risk assessment of fetal trisomy 18 during the first prenatal testing between 11 and 13+6 weeks of pregnancy.
Ziolkowska K; Tobola-Wrobel K; Dydowicz P; Zurawski S; Pietryga M; Wysocka E
Ginekol Pol; 2020; 91(12):748-754. PubMed ID: 33447994
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin and first trimester maternal PAPP-A and hCG levels, fetal nuchal translucency in the first trimester of pregnancy.
Tarim E; Cok T; Hacivelioglu S; Bagis T
Clin Exp Obstet Gynecol; 2011; 38(1):81-3. PubMed ID: 21485734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
